Elicit
AI NativeElicit helps researchers be 10x more evidence-based
Est 2023|Valuation $100M|Raised $33M
Published Sep 16, 2026
Vendor-published usage metrics indicate rapid reported growth over a period. Independent verification of large cumulative user claims is limited in the public record.
| Starting Price | Free (Basic) | Free (Basic) | Free |
| Paid entry | Plus: low per-user monthly (annual billing shown; historical variations exist) | Premium: low-to-mid per-user monthly (monthly or annual options) | Premium tier: low-to-mid per-user monthly or annual pricing; regional variations reported |
| Primary focus | Evidence synthesis, structured extraction, systematic review workflow | Integrated reading, writing, PDF chat, citation workflows | Literature discovery, network mapping, and project organization |
| Key strength | Structured extraction and evidence synthesis workflows; citation/quote traceability | End-to-end reading and writing tools with PDF interaction | Discovery and visual mapping for exploring literature relationships |
| Key weakness | Full-text access limits in paywalled domains; outputs require QA; limited independent review volume | Feature set breadth can add complexity; pricing scales for heavy users | Less focused on structured extraction and systematic review reporting |
—